Canopy Growth (CGC) Stock Price & Analysis

CGC$0.56-0.01 -2.20%
Drug Manufacturers - Specialty & GenericValue StockGrowth Stock
Compare
Market cap$237.59MEnterprise value$354.06MRevenue (TTM)$354.20MMarket position—

Score

65
Bullish
Value
60
Quality
45
Growth
89

AI Analysis

Snapshot

Canopy Growth is a growth-led story right now — Growth 89/100 is the pillar doing the heavy lifting (overall 65/100) in Drug Manufacturers - Specialty & Generic. Under the hood: revenue compounding ~-5% annually over recent years. Street targets still imply ~2478% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

60
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

89
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

45
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Canopy Growth Corporation (CGC) last printed $0.56. Equity value is $237.59M. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2017201820192020202120222023202420252026
$39.9M$77.95M$226.34M$398.77M$546.65M$475.7M$333.25M$297.15M$269M$284.6M

About

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

Canopy Growth (CGC) Stock Price & Analysis

CGC price $0.56 -0.01 -2.20%

Ticker
CGC
Price
$0.56
Change
-0.01 -2.20%
Market cap
$237.59M
Dividend yield
0.00%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
65
Value
60
Quality
45
Growth
89

Stocklytics score rationale: value 60, quality 45, growth 89.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener